risperidone has been researched along with Dizzyness in 6 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe secondary analyses from a 12-week, randomized, open-label trial where adult schizophrenia outpatients receiving risperidone, olanzapine, or aripiprazole were switched to iloperidone." | 5.20 | Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia. ( Alva, G; Citrome, L; Glick, ID; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Weiden, PJ; Winseck, A, 2015) |
| " There was a clear relationship between the number of active alleles and the pharmacokinetic parameters for risperidone and 9-hydroxyrisperidone, but there were no differences for total active moiety." | 2.75 | Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. ( Abad-Santos, F; Gallego-Sandín, S; López-Rodríguez, R; Novalbos, J; Ochoa, D; Román, M, 2010) |
| "Risperidone was measured in plasma using high performance liquid chromatography with ultraviolet detection." | 2.73 | Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers. ( Mahatthanatrakul, W; Nontaput, T; Ridtitid, W; Sunbhanich, M; Wongnawa, M, 2007) |
| "Olanzapine-treated patients had greater HAM-D-21 (p = ." | 2.72 | Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. ( Baker, RW; Brown, EB; Jamal, HH; Perlis, RH; Schuh, LM; Tohen, M; Zarate, CA, 2006) |
| "Both patients presented with fatigue, orthostasis, dry mucous membranes, and the unusual finding of miosis." | 1.31 | Atypical presentation of risperidone toxicity. ( Gummin, DD; Hodge, CH; Jewell, M; Leikin, JB, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citrome, L | 1 |
| Weiden, PJ | 1 |
| Alva, G | 1 |
| Glick, ID | 1 |
| Jackson, R | 1 |
| Mattingly, G | 1 |
| Kianifard, F | 1 |
| Meng, X | 1 |
| Winseck, A | 1 |
| Novalbos, J | 1 |
| López-Rodríguez, R | 1 |
| Román, M | 1 |
| Gallego-Sandín, S | 1 |
| Ochoa, D | 1 |
| Abad-Santos, F | 1 |
| Park, CH | 1 |
| Park, TW | 1 |
| Yang, JC | 1 |
| Lee, KH | 1 |
| Huang, GB | 1 |
| Tong, Z | 1 |
| Park, MS | 1 |
| Chung, YC | 1 |
| Perlis, RH | 1 |
| Baker, RW | 1 |
| Zarate, CA | 1 |
| Brown, EB | 1 |
| Schuh, LM | 1 |
| Jamal, HH | 1 |
| Tohen, M | 1 |
| Mahatthanatrakul, W | 1 |
| Nontaput, T | 1 |
| Ridtitid, W | 1 |
| Wongnawa, M | 1 |
| Sunbhanich, M | 1 |
| Hodge, CH | 1 |
| Jewell, M | 1 |
| Gummin, DD | 1 |
| Leikin, JB | 1 |
5 trials available for risperidone and Dizzyness
| Article | Year |
|---|---|
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dizziness; Female; Humans; Isoxazoles; M | 2015 |
Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.
Topics: Adult; Alleles; Cross-Over Studies; Cytochrome P-450 CYP2D6; Dizziness; Female; Genetic Variation; G | 2010 |
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Bli | 2012 |
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Appetite; Benzodiazepines; Bipolar Disor | 2006 |
Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Antipsychotic Agents; Area Under Curve; Ca | 2007 |
1 other study available for risperidone and Dizzyness
| Article | Year |
|---|---|
Atypical presentation of risperidone toxicity.
Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Diagnosis, Differential; Dizziness; Drug Ove | 2001 |